Results 21 to 30 of about 183,058 (174)

Evaluation of interleukins 37 and 38 and vitamin D status in the serum of women with Graves' disease

Journal of Clinical Laboratory Analysis, Volume 36, Issue 12, December 2022., 2022
Column bar graph of IL‐37 (A), IL‐38 (B) and vitamin D (C) levels in the serum of Graves' disease (GD) patients and controls (CTRL). Column represents median. Bar represents interquartile range (IQR). Significant differences between medians were assessed using Mann–Whitney U test (***p < 0.001).
Hiba Y. Ibrahim, Ghassan M. Sulaiman, Mohamed S. Al‐shammaa, Ali H. Ad'hiah   +3 more
wiley   +1 more source

Medical therapies for melasma

Journal of Cosmetic Dermatology, Volume 21, Issue 9, Page 3707-3728, September 2022., 2022
Abstract Melasma is a common malady affecting all races with a higher incidence in Hispanics, Middle Eastern, Asians, and African origin females (Fitzpatrick skin phototypes III–V). Women are affected much more often than men. Melasma remains a significant cause of cosmetic morbidity and psychosocial embarrassment affecting quality of life ...
Vikram K. Mahajan, Anant Patil, Leszek Blicharz, Martin Kassir, Nellie Konnikov, Michael H. Gold, Mitchel P. Goldman, Hassan Galadari, Mohamad Goldust   +8 more
wiley   +1 more source

Benefits of Long‐Term Continuation of Low‐Dose Methimazole Therapy in the Prevention of Recurrent Hyperthyroidism in Graves’ Hyperthyroid Patients: A Randomized Prospective Controlled Study

International Journal of Endocrinology, Volume 2022, Issue 1, 2022., 2022
Background. The long‐term continuation of the low‐dose antithyroid drug (ATD) beyond the standard duration of ATD therapy of 12–18 months to prevent recurrent hyperthyroidism (RH) is recommended with low quality of evidence. Objectives. To examine whether long‐term continuation of low‐dose ATD beyond the recommended duration of treatment would provide ...
Raweewan Lertwattanarak, Tada Kunavisarut, Sutin Sriussadaporn, Lodovico Rosato   +3 more
wiley   +1 more source

Application of Genetically Encoded Molecular Imaging Probes in Tumor Imaging

Contrast Media &Molecular Imaging, Volume 2022, Issue 1, 2022., 2022
In recent years, imaging technology has made rapid progress to improve the sensitivity of tumor diagnostic. With the development of genetic engineering and synthetic biology, various genetically encoded molecular imaging probes have also been extensively developed.
Meng Du, Ting Wang, Yaozhang Yang, Fengyi Zeng, Yue Li, Zhiyi Chen, Alexander R. Haug   +6 more
wiley   +1 more source

Antigen receptor variable region repertoires expressed by T cells infiltrating thyroid, retroorbital, and pretibial tissue in Graves' disease [PDF]

, 1996
To date, it has remained unclear whether T cells infiltrating thyroid, retroorbital, and pretibial tissue of patients with Graves' ophthalmopathy and pretibial dermopathy represent a primary immune response that is directed against certain antigenic ...
Wenzel, Björn E., Heufelder, Armin E., Scriba, Peter C.   +2 more
core   +1 more source

Differentiated search for disease in a patient with hyperthyroisis with a prevailing syndrome of cardiovascular disorders. Clinical case

Mìžnarodnij Endokrinologìčnij Žurnal, 2022
Background. Elderly patients in the presence of iodi­ne deficiency most often develop functional autonomy of the thyroid gland, accompanied by dysfunction — hyperthyroidism.
L.V. Shkala, T.I. Malchevskaya, O.V. Shkala   +2 more
doaj   +1 more source

Local immune microenvironment of skin may play an important role in the development of pretibial myxedema

Experimental Dermatology, Volume 30, Issue 12, Page 1820-1824, December 2021., 2021
Abstract Pretibial myxedema (PTM), characterized by the accumulation of glycosaminoglycans in dermis is an autoimmune skin disorder, which is almost always associated with Graves’ disease (GD). Although fibroblast stimulated by thyroid‐stimulating hormone receptor (TSHR) antibody, cytokines and growth factors have been postulated as target of the ...
Xiaoying Chen, Jiaoyun Dong, Li Zhang, Xiaoqing Zhao, Ruofei Shi, Meng Pan, Jie Zheng   +6 more
wiley   +1 more source

Rare presentation of Graves’ disease with myalgia: A case report

Clinical Case Reports, Volume 9, Issue 10, October 2021., 2021
It is important to consider the disease mechanism and the presence of other concomitant diseases with Graves’ disease. Thyrotoxicosis could be a differential diagnosis in patients who present with myalgia. Abstract A 42‐year‐old woman presented with myalgia, which ameliorated a week after treatment. She was diagnosed with Graves’ disease.
Masaru Kurihara, Shunichi Kinjo, Yasuharu Tokuda   +2 more
wiley   +1 more source

A Genomic Point Mutation in the Extracellular Domain of the Thyrotropin Receptor in Patients with Graves’ Ophthalmopathy [PDF]

, 1994
Orbital and pretibial fibroblasts are targets of autoimmune attack in Graves' ophthalmopathy (GO) and pretibial dermopathy (PTD). The fibroblast autoantigen involved in these peripheral manifestations of Graves' disease and the reason for the association
Sarkar, Gobinda, Bahn, Rebecca S., Heufelder, Armin E., Dutton, Charyl M., R. S. Bahn   +4 more
core   +1 more source

Severe thyroid eye disease associated with primary hypothyroidism and thyroid-associated dermopathy

Four unusual cases of patients are described with severe thyroid eye disease (TED) who presented with primary hypothyroidism and thyroid- associated dermopathy (TAD). All four patients had moderate or severe TED and elevated circulating thyrotropin (TSH)
Gleeson H, Fleck B, Dickinson J, Kelly W, Toft A, Kendall-Taylor P, Perros P   +6 more
core   +5 more sources